Neuroscientist Maiken Nedergaard Links Aging Diseases to Brain Waste Clearance
Maiken Nedergaard, a neuroscientist at the University of Rochester, has researched the brain's glymphatic system, which clears waste during sleep. She connects impaired clearance to neurodegenerative diseases like Alzheimer's. Her work highlights the role of sleep in brain health.
Substrate placeholder — needs reviewMaiken Nedergaard, a professor of neuroscience and physiology at the University of Rochester Medical Center, has studied the brain's mechanisms for removing waste products. Her research focuses on the glymphatic system, a network of channels that facilitates the clearance of proteins and other substances from the brain.
This system operates primarily during sleep, when cerebrospinal fluid flows through the brain to flush out accumulated waste.
Nedergaard's team discovered the glymphatic system in 2012 through experiments on mice. The findings showed that the system becomes more active when the animals are asleep, allowing for efficient removal of beta-amyloid, a protein linked to Alzheimer's disease. Disruptions in this process, such as those caused by sleep deprivation, lead to waste buildup in the brain.
Nedergaard has stated that diseases associated with aging, including Alzheimer's and Parkinson's, stem from failures in brain waste clearance.
” This perspective underscores how accumulated toxins contribute to neuronal damage over time. Her studies indicate that the glymphatic system's efficiency declines with age, exacerbating the risk of neurodegenerative conditions. Factors like chronic sleep loss, common in modern lifestyles, further impair this clearance mechanism.
Nedergaard's work suggests that improving sleep quality could mitigate these risks.
The research affects millions worldwide affected by aging-related brain disorders.
In the United States alone, over 6 million people live with Alzheimer's, a number projected to rise as populations age. Nedergaard's findings point to potential interventions, such as promoting better sleep hygiene, to support brain health. Ongoing studies in her lab explore ways to enhance glymphatic function, including pharmacological approaches and lifestyle modifications.
Clinical trials may follow to test these strategies in humans. The work emphasizes the importance of sleep in preventing cognitive decline. Nedergaard's contributions have been recognized with awards, including membership in the National Academy of Sciences.
Her research continues to influence neuroscience, providing a foundation for future treatments targeting waste clearance in the brain.
Key Facts
Story Timeline
2 events- 2012
Nedergaard's team discovered the glymphatic system in mice experiments.
1 source@statnews - Ongoing
Nedergaard continues research on glymphatic function and aging diseases.
1 source@statnews
Potential Impact
- 01
Development of drugs targeting glymphatic function may enter clinical trials.
- 02
Increased focus on sleep interventions may reduce Alzheimer's risk in aging populations.
- 03
Research funding for glymphatic studies could expand due to Nedergaard's findings.
- 04
Public health campaigns might promote better sleep hygiene to support brain clearance.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…